Skip to content

the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain

A Multicenter, Prospective Clinical Randomized Controlled Study of the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07405281
Enrollment
208
Registered
2026-02-12
Start date
2026-03-01
Completion date
2029-03-01
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprain

Keywords

acute ankle sprain, hyperbaric oxygen

Brief summary

Investigators recruited 208 patients with acute ankle sprain who were from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University, School of Medicine from January 2026 to November 2028. Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years.

Detailed description

In baseline, 208 patients with i acute ankle sprain were recruited from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University School of Medicine from January 2026 to December 2028, and were followed up after 3 years. Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years. The Hyperbaric oxygen group treatment was administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen was inhaled for 40 minutes (20 minutes of oxygen inhalation, 5-minute rest, 20 minutes of oxygen inhalation, decompression), once daily for 14 consecutive days. The control group treatment at an atmospheric pressure of 1.4 ATA, inhaling 21% oxygen by volume. Oxygen inhalation schedule: 40 minutes (inhale oxygen for 20 minutes, rest for 5 minutes, inhale oxygen for 20 minutes, decompression), once a day for 14 consecutive days. Two person analyzed the above data, and record abnormal results.

Interventions

OTHERhyperbaric oxygen therapy

The treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen inhalation time: 40 minutes (inhaling oxygen for 20 minutes, resting for 5 minutes, inhaling oxygen for 20 minutes, decompression), once daily, for 14 consecutive days. (Commenced immediately after randomisation)

OTHERnon Hyperbaric Oxygen Therapy

The treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%, oxygen inhalation time: 40 minutes (20 minutes of oxygen inhalation, 5 minutes rest, 20 minutes of oxygen inhalation, decompression), once daily, for 14 consecutive days. (Commences immediately after randomisation)

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Unilateral ankle sprain; * Swelling, bruising, and pain at the site of the sprain; * Injury occurring within 72 hours; * MRI examination clearly shows ligament damage.

Exclusion criteria

* X-ray shows ankle fracture; * Ankle has skin lesions or skin diseases; * History of lower limb and pelvic surgery; * Obvious neurological or psychiatric disorders that may interfere with assessment; * Severe ligament injuries or joint instability requiring surgical treatment; * Previous ankle injuries, persistent pain or functional limitations; * Pneumothorax, severe emphysema, active bleeding, or other diseases with contraindications for hyperbaric oxygen therapy.

Design outcomes

Primary

MeasureTime frameDescription
AOFAS score3 yearsImprovement of American Orthopaedic Foot \& Ankle Society Score (AOFAS scores)in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100, higher scores mean a better outcome.
Baird-Jackson ankle score3 yearsImprovement of Baird-Jackson Ankle Evaluation Score(Baird-Jackson ankle scores) in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100., higher scores mean a better outcome.

Secondary

MeasureTime frameDescription
pain scores3 yearsThe effects of hyperbaric oxygen on improvements in pain scores Visual Analog Scale (VAS) (resting VAS and walking VAS) in patients with acute ankle sprain. Usually scored from 0 to 10. higher scores mean a worth outcome.
ankle swelling3 yearsMeasure the ankle joint circumference at the level of the medial malleolus tip, in millimeters, on both the affected and healthy sides, and calculate the degree of swelling. The more swollen the joints, the worth the outcome.
high-frequency ultrasound findings3 yearsObserve the damage and healing of ligaments and surrounding tissues. The better the continuity of the ligaments and surrounding tissues, the better the outcome.
Ankle MRI3 yearsObserve the damage and healing of ligaments and surrounding tissues. The higher the MRI signal, the worse the outcome.
patient's overall evaluation of treatment (PGIC)3 yearsThe doctor asks the patient about their overall feeling regarding the treatment: 'Has there been any improvement?' Choose one as your answer: Number 1 indicates significant improvement; Number 2 indicates slight improvement; Number 3 indicates no change; Number 4 indicates worsening due to the treatment. higher scores mean a worth outcome.
HAMA scale score3 yearsthe effects of hyperbaric oxygen on change in Hamilton Anxiety Scale(HAMA scale score)in patients with acute ankle sprain. Each item is rated on a five-point scale from 0 to 4. The total score reflects the overall severity of anxiety and can be used to assess treatment effects and changes in the condition. Total score ≥29: Possible severe anxiety. Total score ≥21: Definitely significant anxiety. Total score ≥14: Definitely anxiety. Total score ≥7: Possible anxiety. Total score \<7: No anxiety symptoms. higher scores mean a worse outcome.

Contacts

CONTACTBing Xiong, MD
2202030@zju.edu.cn86-13516803156
PRINCIPAL_INVESTIGATORBing Xiong

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026